Dosage and administration
Hold bottle 8 to 10 inches from coat and spray onto affected area.
GNC Pets Hot Spot Spray (Premium Formula)
- Manufacturer
- General Nutrition Corporation | Marianna Industries, Inc
- Effective date
- 2018-11-05
- Label type
- OTC ANIMAL DRUG LABEL
- Version
- 2
- Source
- full-release
- Hydrated at
- 2026-06-01 02:40:18
Label at a glance#
ProductGNC Pets Hot Spot (Premium Formula)
Active ingredientDiphenhydramine Hydrochloride, Hydrocortisone, Benzethonium Chloride
Label structure7 sections
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
342002
FNG
Directions for Use:
Hold bottle 8 to 10 inches from coat and spray onto affected area.
SAFE HANDLING WARNING SECTION
For external use only. Safe for dogs 12 weeks of age and older. Avoid contact with eyes. In case of eye contact, flush thoroughly with water. If condition persists more than 7 days, consult your veterinarian.
SPL UNCLASSIFIED SECTION
Keep out of reach of children and pets.
DESCRIPTION SECTION
| Active Ingredients: | |
| Diphenhydramine Hydrochloride | 0.50% |
| Hydrocortisone | 0.05% |
| Benzethonium Chloride | 0.05% |
SPL UNCLASSIFIED SECTION
Other Ingredients: Water, Alcohol, Glycerin, Sucrose, Polysorbate 20, Panthenol, Tocopheryl Acetate, Retinyl Palmitate, Thiamine Hydrochloride, Cyanocobalamin, DMDM Hydantoin.
For More Information:
1-888-612-1198
SHOP NOW @ PETSMART.COM
Distributed by:
General Nutrition Corporation
Pittsburgh, PA 15222
PRINCIPAL DISPLAY PANEL - 300 mL Bottle Label
MEDICATED +
HOT SPOT
SPRAY
GNC
PETS
PREMIUM FORMULA
S
MEDICATED
SPRAY
Relieves discomfort
associated with hot spots
Helps reduce itching,
swelling and redness
Contains ingredients to
help reduce infection
• MEDICATED CARE
+
• MEDICATED CARE
UNSCENTED
Net Wt. 10.14 fl oz
(300 mL)
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1537194 | diphenhydrAMINE HCl 0.5 % / hydrocortisone 0.05 % / benzethonium Cl 0.05 % Topical Spray | PSN | 2 |
| 1537194 | benzethonium chloride 0.5 MG/ML / diphenhydramine hydrochloride 5 MG/ML / hydrocortisone 0.5 MG/ML Topical Spray | SCD | 2 |
| 1537194 | benzethonium Cl 0.05 % / diphenhydramine HCl 0.5 % / hydrocortisone 0.05 % Topical Spray | SY | 2 |
DailyMed Pharmacologic Classes#
| Class | Version | Type | Effective |
|---|---|---|---|
| DIPHENHYDRAMINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| HYDROCORTISONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 43655-002-01 | GNC Pets Hot Spot (Premium Formula) | 503 mL in 1 BOTTLE, PLASTIC | SPRAY | 503 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 43655-002 | GNC PETS HOT SPOT (PREMIUM FORMULA) (DIPHENHYDRAMINE HYDROCHLORIDE, HYDROCORTISONE, AND BENZETHONIUM CHLORIDE) SPRAY [GENERAL NUTRITION CORPORATION] | 2 | 1 package rows | 20181107_14915788-8e18-4277-adb8-82b79faaabf0.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Benzethonium Chloride | ACTIVE INGREDIENT | PH41D05744 | 1 | |
| Diphenhydramine Hydrochloride | ACTIVE INGREDIENT | TC2D6JAD40 | 1 | |
| Hydrocortisone | ACTIVE INGREDIENT | WI4X0X7BPJ | 1 | |
| Benzethonium | ACTIVE MOIETY | 1VU15B70BP | 1 | |
| Diphenhydramine | ACTIVE MOIETY | 8GTS82S83M | 1 | |
| Hydrocortisone | ACTIVE MOIETY | WI4X0X7BPJ | 1 | |
| .Alpha.-Tocopherol Acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| Cyanocobalamin | INACTIVE INGREDIENT | P6YC3EG204 | 1 | |
| DMDM Hydantoin | INACTIVE INGREDIENT | BYR0546TOW | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Panthenol | INACTIVE INGREDIENT | WV9CM0O67Z | 1 | |
| Polysorbate 20 | INACTIVE INGREDIENT | 7T1F30V5YH | 1 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | 1 | |
| Thiamine Hydrochloride | INACTIVE INGREDIENT | M572600E5P | 1 | |
| Vitamin A Palmitate | INACTIVE INGREDIENT | 1D1K0N0VVC | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- GNC Pets Hot Spot (Premium Formula)
- Diphenhydramine Hydrochloride, Hydrocortisone, and Benzethonium Chloride
- Diphenhydramine Hydrochloride
- Diphenhydramine
- Hydrocortisone
- Benzethonium Chloride
- Benzethonium
- Water
- Alcohol
- Glycerin
- Sucrose
- Polysorbate 20
- Panthenol
- .Alpha.-Tocopherol Acetate
- Vitamin A Palmitate
- Thiamine Hydrochloride
- Cyanocobalamin
- DMDM Hydantoin
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 43655-002 | 43655-002-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Diphenhydramine Hydrochloride | TC2D6JAD40 | ACTIB |
| Hydrocortisone | WI4X0X7BPJ | ACTIB |
| Benzethonium Chloride | PH41D05744 | ACTIB |
| Water | 059QF0KO0R | IACT |
| Alcohol | 3K9958V90M | IACT |
| Glycerin | PDC6A3C0OX | IACT |
| Sucrose | C151H8M554 | IACT |
| Polysorbate 20 | 7T1F30V5YH | IACT |
| Panthenol | WV9CM0O67Z | IACT |
| .Alpha.-Tocopherol Acetate | 9E8X80D2L0 | IACT |
| Vitamin A Palmitate | 1D1K0N0VVC | IACT |
| Thiamine Hydrochloride | M572600E5P | IACT |
| Cyanocobalamin | P6YC3EG204 | IACT |
| DMDM Hydantoin | BYR0546TOW | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | TABLET / ORAL | 17 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | EMULSION / TOPICAL | 2 %w/w | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SUSPENSION / SUBCUTANEOUS | 1.6 %w/v | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | SUPPOSITORY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION / INTRAMUSCULAR | 1.62 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM, AUGMENTED / TOPICAL | 55 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Sucrose | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| Cyanocobalamin | CYANOCOBALAMIN | P6YC3EG204 | SOLUTION / ORAL | 60 mg/1000ml | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | CLOTH / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / TRANSDERMAL | 306.2 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Polysorbate 20 | POLYSORBATE 20 | 7T1F30V5YH | INJECTION, SOLUTION / SUBCUTANEOUS | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Sucrose | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.